3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Failure
1
Leukemia-Lymphoma, Adult T-Cell
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Etoposide
2
prednylidene
1
emvododstat
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Vorinostat
1
Vincristine
1
Rituximab
1
Raltegravir Potassium
1
Prednisone
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Lenalidomide
1
Immunohistochemistry
1
Genes
1
Gene Expression Profiling
1
Doxorubicin
1
Cytarabine
1
Cyclophosphamide
1
Carmustine
1
CT-P10
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
HIV Infections
×
Raltegravir Potassium
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled